• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. CONTOUR TRANSTAR STAPLER SET; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. CONTOUR TRANSTAR STAPLER SET; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number STR5G
Health Effect - Clinical Codes Fistula (1862); Incontinence (1928); Pain (1994); Sepsis (2067); Obstruction/Occlusion (2422); Blood Loss (2597)
Date of Event 01/01/2013
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Date of event: publication year of 2013.Batch # unk.This report is related to a journal article; therefore no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.The single complaint was reported with multiple events through a journal article.No specific patient information regarding events has been provided and it is unknown if the events have been previously reported.Attempts are being made to obtain the following information.If further details are received at the later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.What are the specific "others" adverse event noted in tables 2 and 3, and if the ethicon device caused/contributed to the reported events in the article? does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? (b)(4).
 
Event or Problem Description
It was reported via literature entitled: emerging technologies in coloproctology: results of the italian society of colorectal surgery logbook of adverse events.Author : l.Basso, m.Pescatori, f.La torre, i.Destefano, a.Pulvirenti d¿urso, a.Infantino, a.Amato, aeco group.Citation: tech coloproctol (2013); 17:207¿211.Doi: 10.1007/s10151-012-0906-6.The aim of this study is to present the results of the italian society of colorectal surgery [or societa` italiana di chirurgia colorettale (siccr)] logbook of adverse event (ae) occurring in relation to emerging technologies in coloproctology (etcs), over a 3-year period.A total of 245 patients (155 male and 90 female; age range: 20-75 years) with ae were reported.The ¿¿observations¿¿ originated from the same institution of the aes in 44 cases, while 201 patients had been operated on somewhere else.The three most reported emerging technologies in coloproctology (etc) accounted for 227 observations: procedure for prolapsed haemorrhoids (pph [ethicon]; n = 120; 61 male and 59 female), stapled transanal rectal resection (starr) & starr with contour transtar (ethicon; n = 96; 12 male and 84 female), and transanal haemorrhoidal dearterialization (thd; n = 11; 10 male and 1 female).Reported complications in the pph group included chronic pain (n-46), obstruction (n-27), bleeding (n-19) which required surgical haemostasis, stenosis (n-19), prolapse (n-16), sepsis (n-14), frequency, incontinence, fractioned evacuation (n-14), fissure (n-10), fistula (n-6), perforation (n-6), urgency (n-3), tenesmus (n-3), and others (n-27).In starr group, reported complications included frequency, incontinence, fractioned evacuation (n-33), obstruction (n-26), chronic pain (n-21), bleeding requiring surgical haemostasis (n-18), prolapse (n-18), urgency (n-13), stenosis (n-10), tenesmus (n-4), sepsis (n-3), fistula (n-3), fissure (n-2), and others (n-11).In conclusion, etcs are important, yet they are not without major risks.Manufacturers should help colorectal surgeons to convey the right message to patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR TRANSTAR STAPLER SET
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
MDR Report Key8704169
Report Number3005075853-2019-19799
Device Sequence Number14020320
Product Code GDW
UDI-Device Identifier10705036002871
UDI-Public10705036002871
Combination Product (Y/N)N
Initial Reporter CountryIT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 05/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberSTR5G
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/27/2019
Initial Report FDA Received Date06/17/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-